Market News
Lincoln Pharma Declares 18% Final Dividend, Q4 FY26 Results
Published 2026-05-29 · Bazaar Watch Research
- Lincoln Pharmaceuticals announced an 18% final dividend for the financial year FY26.
- This translates to ₹1.80 per equity share, declared alongside its Q4 FY26 financial results.
- The company reported a net profit of ₹11.63 crore for the fourth quarter of FY26.
- The dividend recommendation is subject to approval by shareholders at the upcoming Annual General Meeting.
